321196-56-9

Upstream product

• 58452-00-9 3-benzyloxy-4-methoxybenzoic acid 
• 57535-57-6 methyl 3-(benzyloxy)-4-methoxy-benzoate 

Downstream Products

• 1251485-47-8 3-(benzyloxy)-N'-(4-fluorobenzoyl)-4-methoxybenzohydrazide 
• 1251485-49-0 3-(benzyloxy)-4-methoxy-N'-(4-(trifluoromethyl)benzoyl)benzohydrazide 
• 1251485-50-3 N'-(3-(benzyloxy)-4-methoxybenzoyl)-3,4,5-trimethoxybenzohydrazide 
• 1251485-51-4 3-(benzyloxy)-N'-(3,4-dimethoxybenzoyl)-4-methoxybenzohydrazide 

Relevant academic research and scientific papers

Synthesis, anticancer activity and mitochondrial mediated apoptosis inducing ability of 2,5-diaryloxadiazole-pyrrolobenzodiazepine conjugates

A series of 2,5-diaryloxadiazole linked pyrrolo[2,1-c][1,4]benzodiazepine conjugates have been prepared and evaluated for their anticancer activity. These conjugates have shown promising activity with GI50 values ranging from a view to understand the mechanism of action of these conjugates.

Triazole derivatives

The present invention relates to triazole and imidazole derivatives of formula I and to their pharmaceutically acceptable acid addition salts. These compounds are NMDA receptor subtype blockers and are useful for the treatment of diseases related to the NMDA receptor.